TWI498538B - Blood component detection device - Google Patents

Blood component detection device Download PDF

Info

Publication number
TWI498538B
TWI498538B TW101113828A TW101113828A TWI498538B TW I498538 B TWI498538 B TW I498538B TW 101113828 A TW101113828 A TW 101113828A TW 101113828 A TW101113828 A TW 101113828A TW I498538 B TWI498538 B TW I498538B
Authority
TW
Taiwan
Prior art keywords
blood component
blood
sampling device
disposed
component detecting
Prior art date
Application number
TW101113828A
Other languages
Chinese (zh)
Other versions
TW201243308A (en
Inventor
Dar Bin Shieh
Original Assignee
Univ Nat Cheng Kung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Cheng Kung filed Critical Univ Nat Cheng Kung
Publication of TW201243308A publication Critical patent/TW201243308A/en
Application granted granted Critical
Publication of TWI498538B publication Critical patent/TWI498538B/en

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

血液成分檢測元件Blood component detecting element

本發明係關於一種血液成分檢測元件及具此元件之血液取樣裝置,尤指一種易於操作、可隨身攜帶之血液成分檢測元件。The present invention relates to a blood component detecting element and a blood sampling device having the same, and more particularly to a blood component detecting element which is easy to handle and can be carried around.

經統計,近年來為慢性疾病所若的病人人數不斷上升。以糖尿病為例,糖尿病患者需定期、定時檢查自身的健康狀況,例如:每八個小時需進行一次自身血液樣品的檢查。血液樣品的檢查係在檢試病患的血液中某種特家化學組成物的濃。如上所述之糖尿病患者,即需檢試糖尿病患者的血糖濃度。因此,對糖尿病患者而言,需每八個小時進行一次血糖濃度檢測。According to statistics, the number of patients suffering from chronic diseases has increased in recent years. In the case of diabetes, patients with diabetes need to check their health regularly and regularly. For example, a blood sample should be taken every eight hours. The blood sample is examined for the concentration of a particular chemical composition in the blood of the patient. The diabetic patient as described above needs to test the blood glucose concentration of the diabetic patient. Therefore, for diabetic patients, blood glucose concentration testing should be performed every eight hours.

其中,因血糖濃度的檢測對糖尿病患者而言極為重要,且需每日、每八個小時進行,因此血糖濃度檢測的步驟或實行儘可能的簡易,以使每一糖尿病患者都能以輕易且簡易的方法來對自身的健康狀況進行檢測與追蹤。更重要的是,習知之血液樣品的取得方法通常是對患者進行抽血,而此舉將增加患者的疼痛感,進而造成患者排斥血糖濃度檢測。Among them, because the detection of blood glucose concentration is extremely important for diabetic patients, and needs to be performed every day, every eight hours, so the steps of blood glucose concentration detection or implementation is as simple as possible, so that every diabetic patient can easily An easy way to detect and track your health. More importantly, the conventional method of obtaining blood samples is usually to draw blood from the patient, and this will increase the pain of the patient, thereby causing the patient to reject the blood glucose concentration detection.

再者,為了維持血糖濃度檢測的精確性,多會於抽血的過程中抽取大量的血液。因此,在抽血過程中多使用大型刺血針(lancet)來進行抽血,以快速抽取血液並獲得大量的血液樣品。然而,此將更增加患者的疼痛感,更加降低患者進行血糖濃度檢測的意願。尤其是年長的患者而言,年長的患者因疼痛感而排斥血糖濃度檢測的意願更加強烈。如此一來,將無法有效的檢測與監控糖尿病患者血糖濃度,糖尿病患者的健康狀況即無法被有效的掌握。Furthermore, in order to maintain the accuracy of blood glucose concentration detection, a large amount of blood is drawn during the blood drawing process. Therefore, a large lancet is used in the blood drawing process to draw blood to quickly draw blood and obtain a large amount of blood sample. However, this will increase the pain of the patient and further reduce the patient's willingness to detect blood glucose. Especially for older patients, older patients are more willing to reject blood glucose levels for pain perception. As a result, the blood glucose concentration of diabetic patients cannot be effectively detected and monitored, and the health status of diabetic patients cannot be effectively grasped.

因此,對糖尿病患者而言,若能發展一種易於操作、可隨身攜帶、並能改善習知血液樣品取得時而造成的疼痛感之血液成分檢測元件,實是糖尿病患者的一大福音。Therefore, it is a great boon for diabetic patients to develop a blood component detecting element that is easy to handle, can be carried around, and can improve the pain caused by the acquisition of a conventional blood sample.

本發明之主要目的係在提供一種一種血液成分檢測元件,俾能隨身攜帶,且易於操作,更能改善血液樣品取得時而造成的疼痛感。SUMMARY OF THE INVENTION The main object of the present invention is to provide a blood component detecting element which can be carried around, is easy to handle, and can improve the pain caused by the blood sample.

為達成上述目的,本發明之一種血液成分檢測元件,包括:一膠囊本體,此膠囊本體係具有一第一表面;一陣列針頭,此陣列針頭係包含複數個針頭,每一此等針頭係具有一開孔及一內部中空空間,而每一此針頭係自此第一表面凸出;一檢測腔體,此檢測腔體係位於此膠囊本體內,並與此內部中空空間連通;一檢測晶片,此檢測晶片係配置於此膠囊本體內;以及複數個感應元件,此等感應元件係配置於此檢測晶片上。In order to achieve the above object, a blood component detecting component of the present invention comprises: a capsule body having a first surface; an array of needles, the array needle comprising a plurality of needles, each of the needles having An opening and an inner hollow space, wherein each of the needles protrudes from the first surface; a detecting cavity, the detecting cavity system is located in the capsule body and communicates with the inner hollow space; The test wafer is disposed in the capsule body; and a plurality of sensing elements are disposed on the detection wafer.

其中,上述之血液成分檢測元件之形狀並無任何限制,然而,於本發明之血液成分檢測元件中,此血液成分檢測元件較佳係呈藥錠(tablet)狀。再者,此血液成分檢測元件較佳係為一拋棄式血液成分檢測元件。The blood component detecting element is not limited in any shape. However, in the blood component detecting element of the present invention, the blood component detecting element is preferably in the form of a tablet. Furthermore, the blood component detecting element is preferably a disposable blood component detecting element.

除此之外,上述之針頭的材料亦無任何限制,然而,於本發明之血液成分檢測元件中,此針頭較佳係由生物可相容材料(biocompatible material)所構成。再者,上述之膠囊本體的材料亦無任何限制,然而,於本發明之血液成分檢測元件中,此膠囊本體較佳係由生物可分解材料(biodegradable material)所構成。In addition, the material of the needle described above is not limited at all. However, in the blood component detecting member of the present invention, the needle is preferably composed of a biocompatible material. Further, the material of the capsule body described above is not limited at all. However, in the blood component detecting member of the present invention, the capsule body is preferably composed of a biodegradable material.

再者,此等針頭上較佳係塗佈有一麻醉劑,藉此,當針頭刺穿過一受測者之皮膚時,受測者因針頭上塗佈有麻醉劑而不會感覺到痛覺。值得注意的是,上述之針頭較佳係以壓印製程(imprinting process)而製得,而另一值得注意的是,上述之壓印製程中所使用之模具則較佳係由微模鑄造法製程(LIGA process)製得。Further, it is preferable that the needles are coated with an anesthetic agent, whereby when the needle is punctured through the skin of a subject, the subject does not feel pain due to the application of the anesthetic on the needle. It should be noted that the above-mentioned needle is preferably made by an imprinting process, and it is also worth noting that the mold used in the above-mentioned imprinting process is preferably a micro-die casting method. Process (LIGA process) is produced.

本發明另再提供一種血液成分檢測裝置,包括:一長條帶,此長條帶係具有一上表面;複數個前述之血液成分檢測元件,此等血液成分檢測元件係設置於此上表面上。其中,此等血液成分檢測元件係以黏貼之方式設置於此第一表面上。而值得注意的是,於上述之血液成分檢測裝置中,相鄰兩此等血液成分檢測元件較佳係等距離設置。The present invention further provides a blood component detecting device comprising: a long strip having an upper surface; a plurality of the aforementioned blood component detecting elements, wherein the blood component detecting elements are disposed on the upper surface . Wherein, the blood component detecting elements are disposed on the first surface in an adhesive manner. It is to be noted that in the blood component detecting device described above, the adjacent two blood component detecting elements are preferably disposed at equal distances.

本發明更再提供一種血液成分取樣裝置,包括:一殼體,此殼體係具有一開口;上述之血液成分檢測裝置,係設置於此殼體內;一彈性元件,係設置於此殼體內;至少一滾筒元件,係用以輸送此血液成分檢測裝置。The present invention further provides a blood component sampling device, comprising: a housing having an opening; the blood component detecting device disposed in the housing; an elastic member disposed in the housing; A roller element is used to transport the blood component detecting device.

其中,上述之彈性元件的形式並無任何限制,任何具有彈性之元件皆可適用於本發明之血液成分取樣裝置中。然而,於本發明之血液成分取樣裝置中,此彈性元件較佳係為一彈簧。除此之外,此血液成分取樣裝置較佳更包括一頂蓋,而此頂蓋較佳係套覆於此殼體之此開口之一端。Wherein, the form of the above elastic member is not limited, and any elastic member can be applied to the blood component sampling device of the present invention. However, in the blood component sampling device of the present invention, the elastic member is preferably a spring. In addition, the blood component sampling device preferably further includes a top cover, and the top cover preferably covers one end of the opening of the housing.

本發明又再提供一種血液成分取樣裝置,包括:一殼體;一指蓋,係設置於此殼體之上;一轉盤,係設置於此殼體之內並具有一中央孔洞,此轉盤係以中央孔為軸心轉動;一深度控制阻件,係具數個子部分,每一此子部分係具有不同之高度;複數個血液成分檢測組,每一此血液成分檢測組係具有一針狀部及一支持部;以及一驅動單元,係包含一固定部及一移動部,且此固定部上係設置有一推動部;其中,此針狀部設位於此推動部之上。The invention further provides a blood component sampling device, comprising: a casing; a finger cover disposed on the casing; a turntable disposed within the casing and having a central hole, the carousel Rotating the central hole as a shaft; a depth control resisting member having a plurality of sub-portions each having a different height; a plurality of blood component detecting groups each having a needle shape And a supporting unit; and a driving unit comprising a fixing portion and a moving portion, wherein the fixing portion is provided with a pushing portion; wherein the needle portion is disposed above the pushing portion.

本發明更再提供一種血液成分取樣裝置,包括:一殼體;一指蓋,係設置於此殼體之上;一轉盤,係設置於此殼體之內並具有一中央孔洞,此轉盤係以中央孔為軸心轉動;複數個血液成分檢測組,每一此血液成分檢測組係具有一針狀部及一支持部;以及一驅動單元,係包含一固定部及一移動部;其中,此固定部係纏繞有一線圈,而此移動部係配置有一永久磁鐵。The invention further provides a blood component sampling device, comprising: a casing; a finger cover disposed on the casing; a turntable disposed inside the casing and having a central hole, the carousel a plurality of blood component detecting groups each having a needle portion and a supporting portion; and a driving unit comprising a fixing portion and a moving portion; wherein The fixing portion is wound with a coil, and the moving portion is provided with a permanent magnet.

其中,於本發明之血液成分取樣裝置,上述之轉盤較佳係順時針轉動、或逆時針轉動。In the blood component sampling device of the present invention, the turntable is preferably rotated clockwise or counterclockwise.

以下係藉由特定的具體實施例說明本發明之實施方式,熟習此技藝之人士可由本說明書所揭示之內容輕易地了解本發明之其他優點與功效。此外,本發明亦可藉由其他不同的具體實施例加以施行或應用,且本說明書中的各項細節亦可基於不同觀點與應用,而在不悖離本發明之精神下進行各種修飾與變更。The embodiments of the present invention are described by way of specific examples, and those skilled in the art can readily appreciate the other advantages and advantages of the present invention. In addition, the present invention may be embodied or applied in various other specific embodiments, and the details of the present invention may be variously modified and changed without departing from the spirit and scope of the invention. .

實施例1Example 1

有關本發明實施例1之血液成分檢測元件,請同時參閱圖1A及圖1B,圖1A係本發明實施例1之血液成分檢測元件之示意圖,而圖1B係本發明實施例1之血液成分檢測元件之側示圖。如圖1A及圖1B所示,本發明實施例1之血液成分檢測元件100係包括:一膠囊本體101、一陣列針頭102、一檢測腔體103、以及一檢測晶片104。Referring to FIG. 1A and FIG. 1B, FIG. 1A is a schematic diagram of a blood component detecting component according to Embodiment 1 of the present invention, and FIG. 1B is a blood component detecting method according to Embodiment 1 of the present invention. Side view of the component. As shown in FIG. 1A and FIG. 1B, the blood component detecting component 100 of the first embodiment of the present invention comprises: a capsule body 101, an array of needles 102, a detecting cavity 103, and a detecting wafer 104.

其中,上述之陣列針頭102係包含複數個針頭1021。除此之外,上述之膠囊本體101係包圍檢測腔體103及檢測晶片104。再者,每一針頭1021係自膠囊本體101之一第一表面1011凸出。而檢測晶片104係位於檢測腔體103的底部。最後,如圖1A所示,本發明實施例1之血液成分檢測元件100係呈一藥錠(tablet)狀。The array needle 102 described above includes a plurality of needles 1021. In addition to the above, the capsule body 101 described above surrounds the detection chamber 103 and the detection wafer 104. Furthermore, each needle 1021 protrudes from a first surface 1011 of the capsule body 101. The detection wafer 104 is located at the bottom of the detection cavity 103. Finally, as shown in Fig. 1A, the blood component detecting element 100 of the first embodiment of the present invention is in the form of a tablet.

如圖1B所示,每一針頭1021的針尖部位係具有一開孔1022,係用於作為一血液樣品(如組織血液)的導入口。再者,每一針頭1021亦具有一內部中空空間1023,用於接受自開孔1022導入的血液樣品,而此內部中空空間1023係位於針頭的本體內。再者,每一針頭1021之本體內的內部中空空間1023係與上述之檢測腔體103連通,使得血液樣品經過內部中空空間1023而被導入至檢測腔體103中,而上述之檢測晶片104即可偵側此血液樣品。此外,如圖1B所示,檢測晶片104之一表面係具有一個或多個感應器105設置於其中,而上述之感應器105係面向檢測腔體103。需注意的是,如上所述,感應器105的數量可為一個或多個,而於本發明實施例1之血液成分檢測元件100中,係使用二個感應器105,以形成一感應器105陣列。As shown in Fig. 1B, the needle tip portion of each needle 1021 has an opening 1022 for use as an introduction port for a blood sample such as tissue blood. Furthermore, each needle 1021 also has an internal hollow space 1023 for receiving a blood sample introduced from the opening 1022, and the internal hollow space 1023 is located within the body of the needle. Furthermore, the inner hollow space 1023 in the body of each needle 1021 is in communication with the detection cavity 103 described above, so that the blood sample is introduced into the detection cavity 103 through the inner hollow space 1023, and the detection wafer 104 is This blood sample can be detected. Further, as shown in FIG. 1B, one surface of the detecting wafer 104 has one or more inductors 105 disposed therein, and the above-described inductor 105 faces the detecting cavity 103. It should be noted that, as described above, the number of the inductors 105 may be one or more, and in the blood component detecting component 100 of the first embodiment of the present invention, two inductors 105 are used to form an inductor 105. Array.

於本發明實施例1之血液成分檢測元件100中,此血液成分檢測元件100係為拋棄式。其中,血液成分檢測元件100上之針頭1021係由生物可相容材料(biocompatible material)所構成,而血液成分檢測元件100上之其他部分則由生物可分解材料(biodegradable material)所構成。除此之外,上述之針頭1021係以壓印製程(imprinting process)而製得。而其中,於壓印製程中所使用之模具則係由微模鑄造法製程(LIGA process)製得,用以維持陣列針頭102中之每一針頭1021在尺寸大小及方向上之高精準度。除此之外,為了提高採集血液樣品的效率,每一針頭1021的針尖上係造以特殊的錐形設計以及溝槽。In the blood component detecting element 100 of the first embodiment of the present invention, the blood component detecting element 100 is of a disposable type. Among them, the needle 1021 on the blood component detecting element 100 is composed of a biocompatible material, and the other portion on the blood component detecting element 100 is composed of a biodegradable material. In addition to the above, the above-mentioned needle 1021 is produced by an imprinting process. Among them, the mold used in the imprint process is made by the LIGA process to maintain the high precision in size and direction of each of the needles 1021 in the array needle 102. In addition, in order to increase the efficiency of collecting blood samples, a special tapered design and grooves are formed on the tip of each needle 1021.

當本發明實施例1之血液成分檢測元件100被用於測定血液樣品中是否有一欲檢測之成分的存在及/或血液樣品中此欲檢測之成分的濃度時,(例如測定血液樣品中某特定之化學組成物、或血糖的濃度),陣列針頭102首先會被驅動。上述之驅動陣列針頭102的方法並無限制,其係可為機械式、電磁式、或手動式驅動。再者,並將針頭1021的針尖部位刺穿過一受測者之皮膚。需注意的是,每一針頭1021上係塗有麻醉劑,因此當針頭1021的針尖部位刺穿過受測者的皮膚時,受測者並不會有痛覺的產生。When the blood component detecting element 100 of the embodiment 1 of the present invention is used for determining whether a blood sample has a component to be detected and/or a concentration of the component to be detected in the blood sample (for example, determining a specific one in the blood sample) The chemical composition, or concentration of blood glucose, the array needle 102 is first driven. The above method of driving the array needle 102 is not limited, and it may be mechanical, electromagnetic, or manual. Further, the needle tip portion of the needle 1021 is pierced through the skin of a subject. It should be noted that each needle 1021 is coated with an anesthetic, so that when the needle tip portion of the needle 1021 is pierced through the skin of the subject, the subject does not have pain.

其中,陣列針頭102的週邊部分係較陣列針頭102的其餘部分早於被壓入至受測者的皮膚,因而使得位於陣列針頭102的週邊部分的針頭1021刺穿入較於陣列針頭102的其餘部分的針頭1021更深的深度,以採集血液樣品。隨後,當血液成分檢測元件100上的針頭1021在札入後受測者的皮膚,即被拉離受測者的皮膚。於此同時,檢測腔體103內即形成有一負壓,此負壓使得血液成分檢測元件100得以抽取受測者的血液樣品,而血液樣品係透過針頭1021上之開孔1022,並流入針頭的本體內。最後,血液樣品即被導入至檢測腔體103內。Wherein, the peripheral portion of the array needle 102 is pressed into the skin of the subject earlier than the rest of the array needle 102, thereby causing the needle 1021 at the peripheral portion of the array needle 102 to penetrate into the rest of the array needle 102. A portion of the needle 1021 is deeper to collect a blood sample. Subsequently, when the needle 1021 on the blood component detecting element 100 is placed on the skin of the subject after being taken, it is pulled away from the skin of the subject. At the same time, a negative pressure is formed in the detecting chamber 103, and the negative pressure causes the blood component detecting element 100 to draw a blood sample of the subject, and the blood sample passes through the opening 1022 of the needle 1021 and flows into the needle. The body. Finally, the blood sample is introduced into the detection chamber 103.

當血液樣品被導入至檢測腔體103後,血液樣品即流至感應器105及檢測晶片104,使血液成分檢測元件100可進行檢測。隨後,檢測晶片104即檢測之結果輸出至一遠端伺服器,以進行後後續之信號處理及分析。其中,檢測之結果即例如為上述之血液樣品中的血糖濃度或血液樣品中某特定之化學組成物。除此之外,遠端伺服器例如可為一血糖儀之微處理器。When the blood sample is introduced into the detection chamber 103, the blood sample flows to the sensor 105 and the detection wafer 104, so that the blood component detecting element 100 can perform detection. Subsequently, the test wafer 104, that is, the result of the detection, is output to a remote server for subsequent signal processing and analysis. The result of the detection is, for example, the blood glucose concentration in the blood sample described above or a specific chemical composition in the blood sample. In addition to this, the remote server can be, for example, a microprocessor of a blood glucose meter.

實施例2Example 2

有關本發明實施例2之血液成分檢測裝置,請參閱圖2,圖2係本發明實施例2之血液成分檢測裝置之示意圖。本發明實施例2之血液成分檢測裝置200之實施方式係與本發明實施例1之血液成分檢測元件100之實施方式相似,其差異處係在於,本發明實施例2之血液成分檢測裝置200更包括一長條帶21,而此長條帶係具有一上表面211。Referring to Fig. 2, Fig. 2 is a schematic diagram of a blood component detecting device according to a second embodiment of the present invention. The embodiment of the blood component detecting device 200 according to the second embodiment of the present invention is similar to the embodiment of the blood component detecting device 100 of the first embodiment of the present invention, and the difference is that the blood component detecting device 200 of the second embodiment of the present invention is further A long strip 21 is included, and the strip has an upper surface 211.

再者,如圖2所,此上表面211係設置有複數個如本發明實施例1中所述之血液成分檢測元件100。除此之外,血液成分檢測元件100係以黏膠黏貼設置於此第一表面211上。其中,相鄰兩血液成分檢測元件100係等距離設置。而其他與本發明實施例1之血液成分檢測元件100相同之實施方式的相關說明便不再多加贅述。Further, as shown in Fig. 2, the upper surface 211 is provided with a plurality of blood component detecting elements 100 as described in Embodiment 1 of the present invention. In addition to this, the blood component detecting element 100 is disposed on the first surface 211 with adhesive adhesion. Among them, the adjacent two blood component detecting elements 100 are equidistantly disposed. Other related descriptions of the same embodiment of the blood component detecting element 100 of the first embodiment of the present invention will not be described again.

實施例3Example 3

有關本發明實施例3之血液成分取樣裝置,請參閱圖3,圖3係本發明實施例3之血液成分取樣裝置之示意圖。如圖3所示,本發明實施例3之血液成分取樣裝置包括:一殼體31,一如本發明實施例2之血液成分檢測裝置200、一彈性元件32、以及至少一滾筒元件33。Referring to Fig. 3, Fig. 3 is a schematic diagram of a blood component sampling device according to a third embodiment of the present invention. As shown in FIG. 3, the blood component sampling device according to Embodiment 3 of the present invention comprises: a casing 31, a blood component detecting device 200 according to Embodiment 2 of the present invention, an elastic member 32, and at least one roller member 33.

其中,上述之殼體31係具有一開口311,而上述之血液成分檢測裝置200係設置於此殼體31內。再者,彈性元件32亦係設置於此殼體31內。值得注意的是,如圖3所,滾筒元件33係用以輸送上述之血液成分檢測裝置200,而血液成分檢測裝置200上之一個血液成分檢測元件100則會對應此開口311而凸出於此殼體31之外。The housing 31 has an opening 311, and the blood component detecting device 200 is disposed in the housing 31. Furthermore, the elastic member 32 is also disposed in the housing 31. It should be noted that, as shown in FIG. 3, the roller member 33 is configured to transport the blood component detecting device 200, and a blood component detecting device 100 on the blood component detecting device 200 protrudes from the opening 311. Outside the housing 31.

再如圖3所示,本發明實施例3之血液成分取樣裝置係更包括一頂蓋34,而此頂蓋34較佳係套覆於此殼體31之此開口311之一端,並形成有一容置空間35。當本發明實施例3之血液成分取樣裝置被使用時,一受測者之手指36先係伸入或穿過此容置空間35。As shown in FIG. 3, the blood component sampling device of the third embodiment of the present invention further includes a top cover 34, and the top cover 34 is preferably sleeved on one end of the opening 311 of the housing 31, and is formed with The accommodation space 35. When the blood component sampling device of the third embodiment of the present invention is used, a finger 36 of a subject first extends into or through the accommodating space 35.

隨後,彈性元件32並推動位於開口311處之血液成分檢測元件100,使血液成分檢測元件100上之針頭得以刺入受測者手指上之皮膚,進行取血的動作。再取得血液後,彈性元件32回推至原始位置,並代動滾筒元件33轉動。藉滾筒元件33之轉動進而代動長條帶,將使用過後的血液成分檢測元件100自開口311輸送開,並將未使過的血液成分檢測元件100輸送至開口311,以進行下一次的血液成分檢測。Subsequently, the elastic member 32 pushes the blood component detecting element 100 located at the opening 311, so that the needle on the blood component detecting element 100 can be inserted into the skin of the subject's finger to perform a blood drawing operation. After the blood is again taken, the elastic member 32 is pushed back to the original position and the roller member 33 is rotated. By the rotation of the roller member 33, the long strip is driven, the used blood component detecting element 100 is transported from the opening 311, and the untreated blood component detecting element 100 is transported to the opening 311 for the next blood. Component detection.

因此,使用過後的血液成分檢測元件100會存放在殼體31內,直到本發明實施例3之血液成分取樣裝置內所搭載的血液成分檢測元件100全部使用過後,一併將血液成分取樣裝置丟棄。藉上述之良好的存放機制,可大幅廢棄降低血液成分檢測元件100處理不當所造成的生物廢棄物問題。Therefore, the blood component detecting element 100 after use is stored in the casing 31, and after the blood component detecting element 100 mounted in the blood component sampling device of the third embodiment of the present invention is used, the blood component sampling device is discarded. . With the above-mentioned good storage mechanism, the problem of bio-waste caused by improper handling of the blood component detecting element 100 can be largely discarded.

實施例4Example 4

有關本發明實施例4之血液成分取樣裝置,請參閱圖4A、圖4B、及圖4C。圖4A係本發明實施例4之血液成分取樣裝置之側示圖,圖4B係本發明實施例4之血液成分取樣裝置之第一示意圖,而圖4C係本發明實施例4之血液成分取樣裝置之第二示意圖。如圖4A、圖4B、及圖4C所示,本發明實施例4之血液成分取樣裝置400係包括:一殼體401、一指蓋402、一轉盤403、一深度控制阻件404、複數個血液成分檢測組405、及一驅動單元406。Referring to Figures 4A, 4B, and 4C, a blood component sampling device according to a fourth embodiment of the present invention. 4A is a side view of a blood component sampling device according to a fourth embodiment of the present invention, FIG. 4B is a first schematic view of a blood component sampling device according to a fourth embodiment of the present invention, and FIG. 4C is a blood component sampling device according to a fourth embodiment of the present invention. The second schematic. As shown in FIG. 4A, FIG. 4B, and FIG. 4C, the blood component sampling device 400 of the fourth embodiment of the present invention includes a housing 401, a finger cover 402, a turntable 403, a depth control resistor 404, and a plurality of The blood component detecting group 405 and a driving unit 406.

其中,此轉盤403係具有一中央孔4031,因此轉盤403具有一對應殼體401之中軸的中央孔4031,使得此轉盤403係可以中央孔4031為軸心轉動。再者,此轉盤403更具有複數個開口4032,而於本發明實施例4之血液成分取樣裝置中,開口4032的數目係為8。此外,每一開口4032係配置有一窗孔4033。The turntable 403 has a central hole 4031. Therefore, the turntable 403 has a central hole 4031 corresponding to the shaft of the housing 401, so that the turntable 403 can be pivoted by the central hole 4031. Furthermore, the turntable 403 further has a plurality of openings 4032, and in the blood component sampling device of the fourth embodiment of the present invention, the number of the openings 4032 is 8. In addition, each opening 4032 is configured with a window hole 4033.

再者,每一血液成分檢測組405係對應轉盤403之一開口4032。其中,於本發明實施例4之血液成分取樣裝置中,每一血液成分檢測組405係具有一針狀部4051、以及一支持部4052。Furthermore, each blood component detecting group 405 corresponds to one opening 4032 of the turntable 403. In the blood component sampling device according to the fourth embodiment of the present invention, each of the blood component detecting groups 405 has a needle portion 4051 and a support portion 4052.

請再參閱圖4A,指蓋402係位於殼體401的頂部。此外,上述之深度控制阻件404則設置於殼體401之內,以控制血液成分檢測組405朝向指蓋402的行進深度。再者,如圖4C所示,上述之深度控制阻件404係包含數個子部分,每一子部分的高度皆不相同,如此可控制控制血液成分檢測組405而有不同的行進深度。亦即,若需要使血液成分檢測組405有較大的行進深度,則藉由可移動上述之深度控制阻件404來達成。其中,移動上述之深度控制阻件404之方式並無任何限制,例如可以電力驅動方式來移動,或以機械方式來移動。Referring again to FIG. 4A, the finger cover 402 is located at the top of the housing 401. In addition, the depth control block 404 described above is disposed within the housing 401 to control the depth of travel of the blood component detecting group 405 toward the finger cover 402. Furthermore, as shown in FIG. 4C, the depth control block 404 includes a plurality of sub-portions, each of which has a different height, so that the blood component detecting group 405 can be controlled to have different depths of travel. That is, if it is necessary to make the blood component detecting group 405 have a large traveling depth, it can be achieved by moving the above-described depth control stopper 404. There is no limitation on the manner of moving the above-mentioned depth control block 404, for example, it can be moved by electric driving or mechanically.

於採集到血液後,轉盤403係轉動至複數個開口4032之其中之一位於指蓋402之下的位置。隨後,深度控制阻件404即被設於一預設位置,以控制血液成分檢測組405的行進深度。After the blood is collected, the turntable 403 is rotated to a position where one of the plurality of openings 4032 is located below the finger cover 402. Subsequently, the depth control block 404 is set at a preset position to control the depth of travel of the blood component detecting group 405.

接下來,將更加詳細地描述與血液成分檢測組405如何向上移動相關的機制係如何由驅動單元406的移動所驅動。請分別參閱圖4D、圖4E、及圖4F。圖4D係本發明實施例4之血液成分取樣裝置之驅動單元之第一示意圖,圖4E係本發明實施例4之血液成分取樣裝置之驅動單元之第二示意圖,而圖4F係本發明實施例4之血液成分取樣裝置之驅動單元之第三示意圖。Next, how the mechanism related to how the blood component detecting group 405 moves upward will be described in more detail how it is driven by the movement of the driving unit 406. Please refer to FIG. 4D, FIG. 4E, and FIG. 4F, respectively. 4D is a first schematic diagram of a driving unit of a blood component sampling device according to Embodiment 4 of the present invention, FIG. 4E is a second schematic diagram of a driving unit of the blood component sampling device according to Embodiment 4 of the present invention, and FIG. 4F is an embodiment of the present invention. A third schematic diagram of the drive unit of the blood component sampling device of 4.

如圖4D所示,驅動單元406係包括一固定部4061及一移動部4062,而固定部4061上係設置有一推動部4064。除此之外,再如圖4D所示,推動部4064係位於血液成分檢測組405之下,而針狀部4051則位於推動部4064之上。As shown in FIG. 4D, the driving unit 406 includes a fixing portion 4061 and a moving portion 4062, and the fixing portion 4061 is provided with a pushing portion 4064. In addition, as shown in FIG. 4D, the pushing portion 4064 is located below the blood component detecting group 405, and the needle portion 4051 is located above the pushing portion 4064.

首先,如圖4D所示,移動部4062係處於一原始位置,如如圖4D中所示之右側。接著,移動部4062朝左側移動,而漸靠近固定部4061。如圖4E所示。當移動部4062漸靠近固定部4061時,係將固定部4061抬升,進而使得推動部4064亦向上抬升,而一併帶動血液成分檢測組405之針狀部4051與支持部4052抬升。First, as shown in Fig. 4D, the moving portion 4062 is in an original position, as shown on the right side as shown in Fig. 4D. Next, the moving portion 4062 moves to the left side and gradually approaches the fixed portion 4061. As shown in Figure 4E. When the moving portion 4062 is gradually approached to the fixing portion 4061, the fixing portion 4061 is raised, and the pushing portion 4064 is also lifted upward, and the needle portion 4051 and the supporting portion 4052 of the blood component detecting group 405 are lifted together.

請再參閱圖4E,值得注意的是,針狀部4051與支持部4052並不會無限制地抬升。如圖4E所示,針狀部4051與支持部4052在抬升一定高度後,深度控制阻件404會卡住支持部4052,以避免針狀部4051與支持部4052無限制地抬升。Referring to FIG. 4E again, it is worth noting that the needle portion 4051 and the support portion 4052 are not lifted without limitation. As shown in FIG. 4E, after the needle portion 4051 and the support portion 4052 are lifted to a certain height, the depth control stopper 404 can catch the support portion 4052 to prevent the needle portion 4051 and the support portion 4052 from being lifted without restriction.

再如圖4F所示,移動部4062續往左側移,並完全移開固定部4061。如此,將使得抬升之固定部4061回復至如圖4D所示之位置。由上述說明可知,當固定部4061抬升至如圖4E中所示之位置時,針狀部4051係可刺入一受測者的皮膚,以進行血液樣品的採集。隨後,再完成血液樣品採集後,轉盤403係旋轉至下一個位置,使另一個開口4032位於指蓋402之下。再者,轉盤403的旋轉方式係可為機械式、電磁式、或以手動方式來驅動。而轉盤403的旋轉方向係可為順時針、或逆時針。As shown in FIG. 4F, the moving portion 4062 continues to move to the left side, and the fixing portion 4061 is completely removed. As such, the raised fixed portion 4061 will be returned to the position shown in FIG. 4D. As can be seen from the above description, when the fixing portion 4061 is raised to the position shown in FIG. 4E, the needle portion 4051 can penetrate the skin of a subject to perform blood sample collection. Subsequently, after the blood sample collection is completed, the turntable 403 is rotated to the next position such that the other opening 4032 is positioned below the finger cover 402. Furthermore, the rotation of the turntable 403 can be mechanical, electromagnetic, or manual. The rotation direction of the turntable 403 can be clockwise or counterclockwise.

當所有血液成分檢測組405上之針狀部4051皆被使用過後,即可將轉盤403自殼體401移除,並置換一未使過的轉盤403。When the needle portions 4051 on all of the blood component detecting groups 405 are used, the turntable 403 can be removed from the housing 401 and replaced with an unreturned turntable 403.

實施例5Example 5

本發明實施例5之血液成分取樣裝置之實施方式係與本發明實施例4之血液成分取樣裝置之實施方式相似,故以下僅針對相異之實施方式做說明,相同之實施方式便不再多加贅述。The embodiment of the blood component sampling device of the fifth embodiment of the present invention is similar to the embodiment of the blood component sampling device of the fourth embodiment of the present invention. Therefore, the following description will be made only for the different embodiments, and the same embodiment will not be added. Narration.

請參閱圖5A、圖5B、及圖5C。圖5A係本發明實施例5之血液成分取樣裝置之驅動單元之第一示意圖,圖5B係本發明實施例5之血液成分取樣裝置之驅動單元之第二示意圖,而圖5C係本發明實施例5之血液成分取樣裝置之驅動單元之第三示意圖。Please refer to FIG. 5A, FIG. 5B, and FIG. 5C. 5A is a first schematic diagram of a driving unit of a blood component sampling device according to Embodiment 5 of the present invention, FIG. 5B is a second schematic diagram of a driving unit of a blood component sampling device according to Embodiment 5 of the present invention, and FIG. 5C is an embodiment of the present invention. A third schematic diagram of the drive unit of the blood component sampling device of 5.

其中,本發明實施例5之血液成分取樣裝置之實施方式與本發明實施例4之血液成分取樣裝置之實施方式的差異係在於:本發明實施例4之血液成分取樣裝置之驅動單元係為機械式,而本發明實施例5之血液成分取樣裝置之驅動單元係為電磁式。The difference between the embodiment of the blood component sampling device according to the fifth embodiment of the present invention and the embodiment of the blood component sampling device of the fourth embodiment of the present invention is that the driving unit of the blood component sampling device according to the fourth embodiment of the present invention is a mechanical device. The driving unit of the blood component sampling device of the fifth embodiment of the present invention is electromagnetic.

請再參閱圖5A,移動部5062係配備有一永久磁鐵501,而支持部5052則纏繞有線圈502。接著,對線圈502通入一電流(圖中未示),線圈502在通入電流後會感應出一磁場(圖中未示)。隨後,在磁交互作用下,移動部5062係向上抬升,如圖5B所示。於此同時,支持部505受移動部5062之推升而被抬升至如圖5B中所示之位置時,針狀部5051係可刺入一受測者的皮膚,以進行血液樣品的採集。Referring to FIG. 5A again, the moving portion 5062 is provided with a permanent magnet 501, and the supporting portion 5052 is wound with the coil 502. Next, a current (not shown) is applied to the coil 502, and the coil 502 induces a magnetic field (not shown) after the current is applied. Subsequently, under the magnetic interaction, the moving portion 5062 is lifted upward as shown in Fig. 5B. At the same time, when the support portion 505 is lifted up to the position shown in FIG. 5B by the moving portion 5062, the needle portion 5051 can penetrate the skin of a subject to perform blood sample collection.

當完成血液樣品的採集後,將通入線圈502上之電流關閉,藉此,使得移動部5062回復至原始之位置,如圖5A所示。When the collection of the blood sample is completed, the current flowing into the coil 502 is turned off, whereby the moving portion 5062 is returned to the original position as shown in Fig. 5A.

上述實施例僅係為了方便說明而舉例而已,本發明所主張之權利範圍自應以申請專利範圍所述為準,而非僅限於上述實施例。The above-mentioned embodiments are merely examples for convenience of description, and the scope of the claims is intended to be limited to the above embodiments.

100、200‧‧‧血液成分檢測元件100, 200‧‧‧ blood component detection components

101‧‧‧膠囊本體101‧‧‧Capsule body

21‧‧‧長條帶21‧‧‧Long strip

102‧‧‧陣列針頭102‧‧‧Array needles

103‧‧‧檢測腔體103‧‧‧Detecting cavity

104‧‧‧檢測晶片104‧‧‧Detection wafer

105‧‧‧感應器105‧‧‧ sensor

1021‧‧‧針頭1021‧‧‧ needle

1011‧‧‧第一表面1011‧‧‧ first surface

1022‧‧‧開孔1022‧‧‧Opening

1023‧‧‧中空空間1023‧‧‧ hollow space

211‧‧‧上表面211‧‧‧ upper surface

31‧‧‧殼體31‧‧‧Shell

32‧‧‧彈性元件32‧‧‧Flexible components

33‧‧‧滾筒元件33‧‧‧Rolling elements

311‧‧‧開口311‧‧‧ openings

34‧‧‧蓋34‧‧‧ Cover

35‧‧‧容置空間35‧‧‧ accommodating space

36‧‧‧手指36‧‧‧ fingers

401‧‧‧殼體401‧‧‧shell

402‧‧‧指蓋402‧‧‧ Finger cover

403‧‧‧轉盤403‧‧‧ Turntable

404‧‧‧深度控制阻件404‧‧‧Deep control block

405‧‧‧血液成分檢測組405‧‧‧ Blood Component Testing Group

406‧‧‧驅動單元406‧‧‧ drive unit

4031‧‧‧中央孔4031‧‧‧Central hole

4032‧‧‧開口4032‧‧‧ openings

4033‧‧‧窗孔4033‧‧‧ window hole

4051‧‧‧針狀部4051‧‧‧ needle department

4052‧‧‧支持部4052‧‧‧Support Department

4061‧‧‧固定部4061‧‧‧Fixed Department

4062‧‧‧移動部4062‧‧‧Mobile Department

4064‧‧‧推動部4064‧‧‧Promotion Department

5062‧‧‧移動部5062‧‧‧Mobile Department

501‧‧‧永久磁鐵501‧‧‧ permanent magnet

5052‧‧‧支持部5052‧‧‧Support Department

502‧‧‧線圈502‧‧‧ coil

5051‧‧‧針狀部5051‧‧‧ needle department

圖1A係本發明實施例1之血液成分檢測元件之示意圖。Fig. 1A is a schematic view showing a blood component detecting element according to a first embodiment of the present invention.

圖1B係本發明實施例1之血液成分檢測元件之側示圖。Fig. 1B is a side view showing a blood component detecting element of Embodiment 1 of the present invention.

圖2係本發明實施例2之血液成分檢測裝置之示意圖。Fig. 2 is a schematic view showing a blood component detecting device according to a second embodiment of the present invention.

圖3係本發明實施例3之血液成分取樣裝置之示意圖。Fig. 3 is a schematic view showing a blood component sampling device according to a third embodiment of the present invention.

圖4A係本發明實施例4之血液成分取樣裝置之側示圖。Fig. 4A is a side view showing a blood component sampling device of a fourth embodiment of the present invention.

圖4B係本發明實施例4之血液成分取樣裝置之第一示意圖。Fig. 4B is a first schematic view showing a blood component sampling device according to a fourth embodiment of the present invention.

圖4C係本發明實施例4之血液成分取樣裝置之第二示意圖。Figure 4C is a second schematic view of the blood component sampling device of Embodiment 4 of the present invention.

圖4D係本發明實施例4之血液成分取樣裝置之驅動單元之第一示意圖。Fig. 4D is a first schematic view showing the driving unit of the blood component sampling device of the fourth embodiment of the present invention.

圖4E係本發明實施例4之血液成分取樣裝置之驅動單元之第二示意圖。Fig. 4E is a second schematic view showing the driving unit of the blood component sampling device of the fourth embodiment of the present invention.

圖4F係本發明實施例4之血液成分取樣裝置之驅動單元之第三示意圖。Fig. 4F is a third schematic view showing the driving unit of the blood component sampling device of the fourth embodiment of the present invention.

圖5A係本發明實施例5之血液成分取樣裝置之驅動單元之第一示意圖。Fig. 5A is a first schematic view showing a driving unit of a blood component sampling device according to a fifth embodiment of the present invention.

圖5B係本發明實施例5之血液成分取樣裝置之驅動單元之第二示意圖。Fig. 5B is a second schematic view showing the driving unit of the blood component sampling device of the fifth embodiment of the present invention.

圖5C係本發明實施例5之血液成分取樣裝置之驅動單元之第三示意圖。Fig. 5C is a third schematic view showing the driving unit of the blood component sampling device of the fifth embodiment of the present invention.

100‧‧‧血液成分檢測元件100‧‧‧ Blood component detection component

101‧‧‧膠囊本體101‧‧‧Capsule body

102‧‧‧陣列針頭102‧‧‧Array needles

103‧‧‧檢測腔體103‧‧‧Detecting cavity

104‧‧‧檢測晶片104‧‧‧Detection wafer

105‧‧‧感應器105‧‧‧ sensor

1021‧‧‧針頭1021‧‧‧ needle

1011‧‧‧第一表面1011‧‧‧ first surface

1022‧‧‧開孔1022‧‧‧Opening

1023‧‧‧中空空間1023‧‧‧ hollow space

Claims (15)

一種血液成分檢測元件,包括:一膠囊本體,該膠囊本體係具有一第一表面以及相對於該第一表面之一第二表面,且該膠囊本體係由生物可分解材料(biodegradable material)所構成;一陣列針頭,該陣列針頭係包含複數個針頭,每一該等針頭係具有一開孔及一內部中空空間,而每一該針頭係自該第一表面凸出,其中,該等針頭係包括一針尖以及一端部,其中,該針尖部之表面與該第一表面所呈之角度係小於該端部之表面與該第一表面所呈之角度,且該等針頭係由生物可相容材料(biocompatible material)所構成;一檢測腔體,該檢測腔體係位於該膠囊本體內,並與該內部中空空間連通;一檢測晶片,該檢測晶片係配置於該膠囊本體內,並設置於該膠囊本體之該第二表面;以及複數個感應元件,該等感應元件係配置於該檢測晶片上。 A blood component detecting component comprising: a capsule body having a first surface and a second surface opposite to the first surface, and the capsule system is composed of a biodegradable material An array of needles, the array of needles comprising a plurality of needles, each of the needles having an opening and an inner hollow space, each of the needles projecting from the first surface, wherein the needles are a needle tip and an end portion, wherein a surface of the tip portion and the first surface are at an angle smaller than an angle between the surface of the end portion and the first surface, and the needles are biocompatible a biocompatible material; a detection cavity, the detection cavity system is located in the capsule body, and is connected to the inner hollow space; a detection wafer, the detection wafer is disposed in the capsule body, and is disposed on the The second surface of the capsule body; and a plurality of sensing elements disposed on the detecting wafer. 如申請專利範圍第1項所述之血液成分檢測元件,其中,該血液成分檢測元件係呈藥錠(tablet)狀。 The blood component detecting element according to claim 1, wherein the blood component detecting element is in the form of a tablet. 如申請專利範圍第1項所述之血液成分檢測元件,其中,該血液成分檢測元件係為一拋棄式血液成分檢測元件。 The blood component detecting element according to claim 1, wherein the blood component detecting element is a disposable blood component detecting element. 如申請專利範圍第1項所述之血液成分檢測元件,其中,該等針頭係塗佈有一麻醉劑。 The blood component detecting element according to claim 1, wherein the needles are coated with an anesthetic. 如申請專利範圍第1項所述之血液成分檢測元件,其中,該等針頭係以壓印製程(imprinting process)而製得。 The blood component detecting element according to claim 1, wherein the needles are produced by an imprinting process. 如申請專利範圍第1項所述之血液成分檢測元件,其中,該壓印製程中所使用之模具則係由微模鑄造法製程(LIGA process)製得。 The blood component detecting element according to claim 1, wherein the mold used in the imprinting process is produced by a LIGA process. 一種血液成分取樣裝置,包括:一血液成分檢測元件,包括一長條帶,該長條帶係具有一上表面;以及複數個如申請專利範圍第1至6項任一項所述之血液成分檢測元件,該等血液成分檢測元件係設置於該上表面上;一殼體,該殼體係具有一開口;一彈性元件,係設置於該殼體內;以及至少一滾筒元件,係用以輸送該血液成分檢測裝置;其中,該長條帶以及該些血液成分檢測元件係設置於該殼體內。。 A blood component sampling device comprising: a blood component detecting element comprising a long strip having an upper surface; and a plurality of blood components according to any one of claims 1 to 6 a detecting component, wherein the blood component detecting component is disposed on the upper surface; a casing having an opening; an elastic component disposed in the casing; and at least one roller component for conveying the a blood component detecting device; wherein the long strip and the blood component detecting elements are disposed in the housing. . 如申請專利範圍第7項所述之血液成分取樣裝置,其中,該等血液成分檢測元件係以黏貼之方式設置於該第一表面上。 The blood component sampling device according to claim 7, wherein the blood component detecting elements are disposed on the first surface in an adhesive manner. 如申請專利範圍第7項所述之血液成分取樣裝置,其中,相鄰兩該等血液成分檢測元件係等距離設置。 The blood component sampling device according to claim 7, wherein the two adjacent blood component detecting elements are equidistantly disposed. 如申請專利範圍第7項所述之血液成分取樣裝置,其中,該彈性元件係為一彈簧。 The blood component sampling device according to claim 7, wherein the elastic member is a spring. 如申請專利範圍第7項所述之血液成分取樣裝置,其中,該血液成分取樣裝置更包括一頂蓋,該頂蓋係套覆於該殼體之該開口之一端。 The blood component sampling device of claim 7, wherein the blood component sampling device further comprises a top cover covering one end of the opening of the housing. 一種血液成分取樣裝置,包括:一殼體;一指蓋,係設置於該殼體之上;一轉盤,係設置於該殼體之內並具有一中央孔洞,該轉盤係以中央孔為軸心轉動;一深度控制阻件,係具數個子部分,每一該子部分係具有不同之高度;複數個血液成分檢測組,每一該血液成分檢測組係具有一針狀部及一支持部;以及一驅動單元,係包含一固定部及一移動部,且該固定部上係設置有一推動部;其中,該針狀部設位於該推動部之上。 A blood component sampling device includes: a casing; a finger cover disposed on the casing; a turntable disposed within the casing and having a central hole, the carousel being centered on the shaft a rotation control unit having a plurality of sub-portions each having a different height; a plurality of blood component detecting groups each having a needle portion and a support portion And a driving unit comprising a fixing portion and a moving portion, and the fixing portion is provided with a pushing portion; wherein the needle portion is disposed above the pushing portion. 如申請專利範圍第12項所述之血液成分取樣裝置,其中,該轉盤係順時針轉動、或逆時針轉動。 The blood component sampling device according to claim 12, wherein the turntable rotates clockwise or counterclockwise. 一種血液成分取樣裝置,包括:一殼體;一指蓋,係設置於該殼體之上;一轉盤,係設置於該殼體之內並具有一中央孔洞,該轉盤係以中央孔為軸心轉動;複數個血液成分檢測組,每一該血液成分檢測組係具有一針狀部及一支持部;以及一驅動單元,係包含一固定部及一移動部; 其中,該固定部係纏繞有一線圈,而該移動部係配置有一永久磁鐵。 A blood component sampling device includes: a casing; a finger cover disposed on the casing; a turntable disposed within the casing and having a central hole, the carousel being centered on the shaft a plurality of blood component detecting groups each having a needle portion and a supporting portion; and a driving unit comprising a fixing portion and a moving portion; Wherein, the fixing portion is wound with a coil, and the moving portion is provided with a permanent magnet. 如申請專利範圍第14項所述之血液成分取樣裝置,其中,該轉盤係順時針轉動、或逆時針轉動。 The blood component sampling device according to claim 14, wherein the turntable rotates clockwise or counterclockwise.
TW101113828A 2011-04-22 2012-04-18 Blood component detection device TWI498538B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161478148P 2011-04-22 2011-04-22

Publications (2)

Publication Number Publication Date
TW201243308A TW201243308A (en) 2012-11-01
TWI498538B true TWI498538B (en) 2015-09-01

Family

ID=48093833

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101113828A TWI498538B (en) 2011-04-22 2012-04-18 Blood component detection device

Country Status (1)

Country Link
TW (1) TWI498538B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060055090A1 (en) * 2003-01-16 2006-03-16 Lee Seung-Seob Method for manufacturing of polymer micro needle array with liga process
CN1273831C (en) * 2001-06-12 2006-09-06 生命扫描有限公司 Device and method for sampling and measuring body fluid component of organism
WO2006116242A2 (en) * 2005-04-25 2006-11-02 Infotonics Technology Center, Inc. Microneedle with glucose sensor and method thereof
US20070191696A1 (en) * 2006-02-16 2007-08-16 Reinhold Mischler Microneedle arrays with atr sensor
US20090005664A1 (en) * 2000-11-21 2009-01-01 Dominique Freeman Blood Testing Apparatus Having a Rotatable Cartridge with Multiple Lancing Elements and Testing Means
US20100069792A1 (en) * 2006-11-10 2010-03-18 National Institute Of Advanced Industrial Science And Technology Biosensor cartridge, biosensor device, sample collecting method, manufacturing method of biosensor cartridge, and needle integral sensor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005664A1 (en) * 2000-11-21 2009-01-01 Dominique Freeman Blood Testing Apparatus Having a Rotatable Cartridge with Multiple Lancing Elements and Testing Means
CN1273831C (en) * 2001-06-12 2006-09-06 生命扫描有限公司 Device and method for sampling and measuring body fluid component of organism
US20060055090A1 (en) * 2003-01-16 2006-03-16 Lee Seung-Seob Method for manufacturing of polymer micro needle array with liga process
WO2006116242A2 (en) * 2005-04-25 2006-11-02 Infotonics Technology Center, Inc. Microneedle with glucose sensor and method thereof
US20070191696A1 (en) * 2006-02-16 2007-08-16 Reinhold Mischler Microneedle arrays with atr sensor
US20100069792A1 (en) * 2006-11-10 2010-03-18 National Institute Of Advanced Industrial Science And Technology Biosensor cartridge, biosensor device, sample collecting method, manufacturing method of biosensor cartridge, and needle integral sensor

Also Published As

Publication number Publication date
TW201243308A (en) 2012-11-01

Similar Documents

Publication Publication Date Title
AU2012245587B2 (en) Tissue penetration device
US7041068B2 (en) Sampling module device and method
EP1978865B1 (en) Tissue penetration device
EP1996914B1 (en) Method for loading penetrating members in a collection device during manufacture
US20130281808A1 (en) Blood component detection device
US20070191736A1 (en) Method for loading penetrating members in a collection device
US20070142748A1 (en) Tissue penetration device
US20130053660A1 (en) Blood Component Detection Device
US20090209883A1 (en) Tissue penetrating apparatus
US20030212424A1 (en) Method and apparatus for lancet actuation
US20070276290A1 (en) Tissue Penetrating Apparatus
JP2017140464A (en) Integrated lancing device
EP2713880A1 (en) Methods and apparatus for lancet actuation
EP1968461A2 (en) Tissue penetration device
TWI498538B (en) Blood component detection device
TW201340944A (en) Capacitive sensor
AU2012268588A1 (en) Integrated lancing device

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees